Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,365,579
-
Share change
-
+299,164
-
Total reported value
-
$9,190,000
-
Price per share
-
$6.73
-
Number of holders
-
1
-
Value change
-
+$2,013,298
-
Number of buys
-
1
Institutional Holders of PROTAGONIST THERAPEUTICS INC - COM as of Q4 2018
As of 31 Dec 2018,
PROTAGONIST THERAPEUTICS INC - COM was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1,365,579 shares.
The largest 1 holders included
PERCEPTIVE ADVISORS LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.